Medical diagnostic accuracy measures: an innovative approach based on the area under predictive values curves.

Positive and negative estimates are commonly used by clinicians to evaluate the likelihood of a disease stage being present based on test results. The predicted values are dependent on the prevalence of the underlying illness. However, for certain diseases or clinical conditions, the prevalence is unknown or different from one region to another or from one population to another, leading to an erroneous diagnosis. This article introduces innovative post-test diagnostic precision measures for continuous tests or biomarkers based on the combined areas under the predictive value curves for all possible prevalence values. The proposed measures do not vary as a function of the prevalence of the disease. They can be used to compare different diagnostic tests and/or biomarkers' abilities for rule-in, rule-out, and overall accuracy based on the combined areas under the predictive value curves. The relationship of the proposed measures to other diagnostic accuracy measures is discussed. We illustrate the proposed measures numerically and use a real data example on breast cancer.

Performance of diagnostic tests based on continuous bivariate markers.

In medical diagnostic research, it is customary to collect multiple continuous biomarker measures to improve the accuracy of diagnostic tests. A prevalent practice is to combine the measurements of these biomarkers into one single composite score. However, incorporating those biomarker measurements into a single score depends on the combination of methods and may lose vital information needed to make an effective and accurate decision. Furthermore, a diagnostic cut-off is required for such a combined score, and it is difficult to interpret in actual clinical practice. The paper extends the classical biomarkers' accuracy and predictive values from univariate to bivariate markers. Also, we will develop a novel pseudo-measures system to maximize the vital information from multiple biomarkers. We specified these pseudo-and-or classifiers for the true positive rate, true negative rate, false-positive rate, and false-negative rate. We used them to redefine classical measures such as the Youden index, diagnostics odds ratio, likelihood ratios, and predictive values. We provide optimal cut-off point selection based on the modified Youden index with numerical illustrations and real data analysis for this paper's newly developed pseudo measures.

Post-test diagnostic accuracy measures under tree ordering of disease classes.

The medical field commonly employs post-test measures such as predictive values and likelihood ratios to assess diagnostic accuracy. Predictive values, including positive and negative values (PPV and NPV), indicate the probability that individuals have a target health condition based on test results. On the other hand, likelihood ratios, including positive and negative ratios (LR+ and LR- respectively), compare the probability of a particular test result between the diseased and non-diseased groups. While predictive values are useful in evaluating diagnostic test accuracy in populations with varying disease prevalence, likelihood ratios provide a direct link between pre-test and post-test probabilities in specific patients. In this study, we introduce and analyze a new approach called generalized predictive values and likelihood ratios, using a tree ordering of disease classes. We evaluate the effectiveness of these methods through simulation studies and illustrate their use with real data on lung cancer.

Increasing character strength knowledge, interest, and skill: preliminary evidence for a collaborative and multimethod assessment procedure.

Introduction: The study's objective was to evaluate whether a qualitative, collaborative, and multimethod assessment protocol increased reports of character strength interest, knowledge, and perceived skills. Methods: Thirty-two participants completed three phases of data collection. Participants were first screened for well-being, which was used as an auxiliary covariate to order participants into experimental conditions. Selected participants were randomly assigned to a control or collaborative and multimethod assessment (card sort × qualitative interview) condition. Participants completed pre- and post-measures of strength interest, knowledge, and perceived skill. In the final phase, second phase participants were invited to report on strength-related outcomes 24 h post-administration using an online survey. Results: A series of 2 (Assessment Condition) × 3 (Time) mixed ANOVAs were analyzed. Results revealed a significant assessment condition by time interaction for strength knowledge and perceived skill. Participants in the collaborative and multimethod assessment condition reported higher strength knowledge and perceived skills compared to control participants. These effects were maintained for 24 h. Conclusion: The findings offer preliminary yet sizable support for using collaborative and multimethod assessment procedures to increase strength knowledge and perceived skill. Because of the qualitative, collaborative, and individualized nature of our assessment protocol, the findings offer a low-cost and contextually bound pathway to increase strength-based outcomes.

On diagnostic accuracy measure with cut-points criterion for ordinal disease classification based on concordance and discordance.

The accuracy of a diagnostic test has always been essential in detecting disease staging. Many diagnostic tests of accuracy measures are used in binary diagnosis tests. Some measures apply to multi-stage diagnosis. Yet, there are limitations to the implementation, and the performance highly depends on the distribution of diagnostic outcomes. Another essential aspect of medical diagnostic testing using biomarkers is to find an optimal cut-point that categorizes a patient as diseased or healthy. This aspect was extended to the diseases with more than two stages. We propose a diagnostic accuracy measure and optimal cut-points selection (CD), using concordance and discordance for k-stages diseases. The CD measure uses the classification agreement and disagreement between tests outcomes and diseases stages. Simulations for power studies suggest that CD can detect the differences between the null and alternative hypotheses that other methods cannot for some scenarios. Simulation results indicate that using CD measures to select optimal cut-points can provide relatively high correct classification rates than the existing measures and more balanced accurate classification rates than the generalized Youden Index (GYI). An illustration is provided using the ANDI data to choose biomarkers for diagnosing Alzheimer's Disease (AD) and select optimal cut-points for the chosen biomarkers.

Misclassification simulation extrapolation method for a Weibull accelerated failure time model.

The problem of misclassification in covariates is ubiquitous in survival data and often leads to biased estimates. The misclassification simulation extrapolation method is a popular method to correct this bias. However, its impact on Weibull accelerated failure time models has not been studied. In this paper, we study the bias caused by misclassification in one or more binary covariates in Weibull accelerated failure time models and explore the use of the misclassification simulation extrapolation in correcting for this bias, along with its asymptotic properties. Simulation studies are carried out to investigate the numerical properties of the resulting estimator for finite samples. The proposed method is then applied to colon cancer data obtained from the cancer registry at Memorial Sloan Kettering Cancer Center.

On Cox proportional hazards model performance under different sampling schemes.

Cox's proportional hazards model (PH) is an acceptable model for survival data analysis. This work investigates PH models' performance under different efficient sampling schemes for analyzing time to event data (survival data). We will compare a modified Extreme, and Double Extreme Ranked Set Sampling (ERSS, and DERSS) schemes with a simple random sampling scheme. Observations are assumed to be selected based on an easy-to-evaluate baseline available variable associated with the survival time. Through intensive simulations, we show that these modified approaches (ERSS and DERSS) provide more powerful testing procedures and more efficient estimates of hazard ratio than those based on simple random sampling (SRS). We also showed theoretically that Fisher's information for DERSS is higher than that of ERSS, and ERSS is higher than SRS. We used the SEER Incidence Data for illustration. Our proposed methods are cost saving sampling schemes.

A Nationwide Study of the "July Effect" Concerning Postpartum Hemorrhage and Its Risk Factors at Teaching Hospitals across the United States.

Objective To assess the "July effect" and the risk of postpartum hemorrhage (PPH) and its risk factors across the U.S. teaching hospitals. Method This study used the 2018 Nationwide Inpatient Sample (NIS) and included 2,056,359 of 2,879,924 single live-birth hospitalizations with low-risk pregnancies across the U.S. teaching hospitals. The International Classification of Diseases, Tenth Revision (ICD-10) from the American Academy of Professional Coders (AAPC) medical coding was used to identify PPH and other study variables. Multivariable logistic regression models were used to compare the adjusted odds of PPH risk in the first and second quarters of the academic year vs. the second half of the academic year. Results Postpartum hemorrhage occurred in approximately 4.19% of the sample. We observed an increase in the adjusted odds of PPH during July through September (adjusted odds ratios (AOR), 1.05; confidence interval (CI), 1.02-1.10) and October through December (AOR, 1.07; CI, 1.04-1.12) compared to the second half of the academic year (January to June). Conclusions This study showed a significant "July effect" concerning PPH. However, given the mixed results concerning maternal outcomes at the time of childbirth other than PPH, more research is needed to investigate the "July effect" on the outcomes of the third stage of labor. This study's findings have important implications for patient safety interventions concerning MCH.

Net benefit of diagnostic tests for multistate diseases: an indicator variables approach.

A limitation of the common measures of diagnostic test performance, such as sensitivity and specificity, is that they do not consider the relative importance of false negative and false positive test results, which are likely to have different clinical consequences. Therefore, the use of classification or prediction measures alone to compare diagnostic tests or biomarkers can be inconclusive for clinicians. Comparing tests on net benefit can be more conclusive because clinical consequences of misdiagnoses are considered. The literature suggested evaluating the binary diagnostic tests based on net benefit, but did not consider diagnostic tests that classify more than two disease states, e.g., stroke subtype (large-artery atherosclerosis, cardioembolism, small-vessel occlusion, stroke of other determined etiology, stroke of undetermined etiology), skin lesion subtype, breast cancer subtypes (benign, mass, calcification, architectural distortion, etc.), METAVIR liver fibrosis state (F0- F4), histopathological classification of cervical intraepithelial neoplasia (CIN), prostate Gleason grade, brain injury (intracranial hemorrhage, mass effect, midline shift, cranial fracture) . Other diseases have more than two stages, such as Alzheimer's disease (dementia due to Alzheimer's disease, mild cognitive disability (MCI) due to Alzheimer's disease, and preclinical presymptomatics due to Alzheimer's disease). In diseases with more than two states, the benefits and risks may vary between states. This paper extends the net-benefit approach of evaluating binary diagnostic tests to multi-state clinical conditions to rule-in or rule-out a clinical condition based on adverse consequences of work-up delay (due to false negative test result) and unnecessary workup (due to false positive test result). We demonstrate our approach with numerical examples and real data.

Inference on P(X < Y) in Bivariate Lomax model based on progressive type II censoring.

This article considers the estimation of the stress-strength reliability parameter, θ = P(X < Y), when both the stress (X) and the strength (Y) are dependent random variables from a Bivariate Lomax distribution based on a progressive type II censored sample. The maximum likelihood, the method of moments and the Bayes estimators are all derived. Bayesian estimators are obtained for both symmetric and asymmetric loss functions, via squared error and Linex loss functions, respectively. Since there is no closed form for the Bayes estimators, Lindley's approximation is utilized to derive the Bayes estimators under these loss functions. An extensive simulation study is conducted to gauge the performance of the proposed estimators based on three criteria, namely, relative bias, mean squared error, and Pitman nearness probability. A real data application is provided to illustrate the performance of our proposed estimators through bootstrap analysis.

Joint inference about the AUC and Youden index for paired biomarkers.

It is common to compare biomarkers' diagnostic or prognostic performance using some summary ROC measures such as the area under the ROC curve (AUC) or the Youden index. We propose to compare two paired biomarkers using both the AUC and the Youden index since the two indices describe different aspects of the ROC curve. This comparison can be made by estimating the joint confidence region (an elliptical area) of the differences of the paired AUCs and the Youden indices. Furthermore, for deciding if one marker is better than the other in terms of both the AUC and the Youden index (J), we can test H0:AUCa≤AUCb or Ja≤Jb against Ha:AUCa>AUCb and Ja>Jb using the paired differences. The construction of such a joint hypothesis is an example of the multivariate order-restricted hypotheses. For such a hypothesis, we propose and compare three testing procedures: (1) the intersection-union test ( IUT ); (2) the conditional test; and (3) the joint test. The performance of the proposed inference methods was evaluated and compared through simulations. The simulation results demonstrate that the proposed joint confidence region maintains the desired confidence level, and all three tests maintain the type I error under the null. Furthermore, among the three proposed testing methods, the conditional test is the preferred approach with markedly larger power consistently than the other two competing methods.

Notes on the overlap measure as an alternative to the Youden index: How are they related?

The receiver operating characteristic (ROC) curve is frequently used to evaluate and compare diagnostic tests. As one of the ROC summary indices, the Youden index measures the effectiveness of a diagnostic marker and enables the selection of an optimal threshold value (cut-off point) for the marker. Recently, the overlap coefficient, which captures the similarity between 2 distributions directly, has been considered as an alternative index for determining the diagnostic performance of markers. In this case, a larger overlap indicates worse diagnostic accuracy, and vice versa. This paper provides a graphical demonstration and mathematical derivation of the relationship between the Youden index and the overlap coefficient and states their advantages over the most popular diagnostic measure, the area under the ROC curve. Furthermore, we outline the differences between the Youden index and overlap coefficient and identify situations in which the overlap coefficient outperforms the Youden index. Numerical examples and real data analysis are provided.

Improved nonparametric estimation of the optimal diagnostic cut-off point associated with the Youden index under different sampling schemes.

A diagnostic cut-off point of a biomarker measurement is needed for classifying a random subject to be either diseased or healthy. However, the cut-off point is usually unknown and needs to be estimated by some optimization criteria. One important criterion is the Youden index, which has been widely adopted in practice. The Youden index, which is defined as the maximum of (sensitivity + specificity -1), directly measures the largest total diagnostic accuracy a biomarker can achieve. Therefore, it is desirable to estimate the optimal cut-off point associated with the Youden index. Sometimes, taking the actual measurements of a biomarker is very difficult and expensive, while ranking them without the actual measurement can be relatively easy. In such cases, ranked set sampling can give more precise estimation than simple random sampling, as ranked set samples are more likely to span the full range of the population. In this study, kernel density estimation is utilized to numerically solve for an estimate of the optimal cut-off point. The asymptotic distributions of the kernel estimators based on two sampling schemes are derived analytically and we prove that the estimators based on ranked set sampling are relatively more efficient than that of simple random sampling and both estimators are asymptotically unbiased. Furthermore, the asymptotic confidence intervals are derived. Intensive simulations are carried out to compare the proposed method using ranked set sampling with simple random sampling, with the proposed method outperforming simple random sampling in all cases. A real data set is analyzed for illustrating the proposed method.

Daily walking and life expectancy of elderly people in the iowa 65+ rural health study.

The purpose of this paper is to investigate the hypothesis that outdoor daily walking, as an exercise, has an effect on the rate of mortality among those elderly people in the Iowa 65+ Rural Health Study (RHS). RHS is a prospective longitudinal cohort study of 8 years follow-up from 1981 to 1989. It consists of a random sample of 3,673 individuals (1,420 men and 2,253 women) aged 65 or older living in Washington and Iowa counties of the State of Iowa. Our analysis was conducted only on those non-institutional individuals who could without any help walk across a small room; this reduced the total number of individuals in the study to 2,717. Moreover, a total of 923 individuals died during the period of the study. The life histories of those individuals were obtained and divided into two cohorts; one containing 1,134 who exercise daily by walking and the other containing 1,583 who do not exercise daily by walking. The interviewers asked participants about 17 medical conditions, from which 13 are included in our study. We found that daily walking exercise is related inversely to total mortality before and after adjusting for the other factors in particular for age group and health conditions. We observed that hazard ratio (HR) of death was the highest among those individuals having a history of cancer (HR = 2.971) and history of stroke (HR = 2.127). However, individuals with a history of stroke in the "daily walking group" have HR = 0.856 and their risk of death were reduced by 81% compared to those in no "daily walking group."